Stevens Capital Management LP Has $17.70 Million Holdings in CME Group Inc. (NASDAQ:CME)

Stevens Capital Management LP increased its position in shares of CME Group Inc. (NASDAQ:CME) by 11.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 83,213 shares of the financial services provider’s stock after acquiring an additional 8,213 shares during the period. CME Group makes up about 5.2% of Stevens Capital Management LP’s holdings, making the stock its 3rd biggest position. Stevens Capital Management LP’s holdings in CME Group were worth $17,698,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp raised its holdings in shares of CME Group by 17.8% in the 1st quarter. Bank of New York Mellon Corp now owns 6,640,423 shares of the financial services provider’s stock valued at $1,356,174,000 after acquiring an additional 1,004,852 shares in the last quarter. Vontobel Asset Management Inc. increased its position in shares of CME Group by 44.1% in the first quarter. Vontobel Asset Management Inc. now owns 2,829,641 shares of the financial services provider’s stock worth $599,650,000 after purchasing an additional 865,745 shares during the last quarter. Edgewood Management LLC raised its stake in CME Group by 6.1% in the first quarter. Edgewood Management LLC now owns 9,680,066 shares of the financial services provider’s stock valued at $1,976,960,000 after purchasing an additional 555,111 shares in the last quarter. Parnassus Investments CA lifted its position in CME Group by 9.7% during the second quarter. Parnassus Investments CA now owns 6,145,717 shares of the financial services provider’s stock valued at $1,307,071,000 after purchasing an additional 541,757 shares during the last quarter. Finally, Primecap Management Co. CA grew its stake in CME Group by 80.6% in the 1st quarter. Primecap Management Co. CA now owns 1,101,430 shares of the financial services provider’s stock worth $224,945,000 after buying an additional 491,700 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

In related news, insider Sean Tully sold 5,000 shares of CME Group stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total transaction of $1,001,000.00. Following the sale, the insider now directly owns 23,479 shares in the company, valued at $4,700,495.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martin J. Gepsman sold 1,000 shares of the firm’s stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $201.37, for a total value of $201,370.00. The disclosure for this sale can be found here. Insiders have sold 9,000 shares of company stock worth $1,786,150 over the last three months. Insiders own 0.30% of the company’s stock.

CME has been the topic of several research reports. Atlantic Securities raised shares of CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price objective for the company in a report on Tuesday, September 14th. Morgan Stanley lifted their price target on CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 1st. TheStreet lowered CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Finally, Berenberg Bank reaffirmed a “hold” rating on shares of CME Group in a research note on Wednesday, September 15th. One analyst has rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $210.83.

CME Group stock traded up $2.66 during trading hours on Monday, reaching $200.67. The stock had a trading volume of 14,742 shares, compared to its average volume of 1,449,153. The company has a fifty day simple moving average of $201.30 and a 200-day simple moving average of $207.06. CME Group Inc. has a 52 week low of $146.89 and a 52 week high of $221.82. The stock has a market cap of $72.07 billion, a PE ratio of 37.01 and a beta of 0.43. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.59 by $0.05. CME Group had a net margin of 41.64% and a return on equity of 8.33%. The company had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.17 billion. Research analysts predict that CME Group Inc. will post 6.65 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Stockholders of record on Friday, September 10th will be given a $0.90 dividend. The ex-dividend date of this dividend is Thursday, September 9th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.79%. CME Group’s dividend payout ratio is currently 53.57%.

CME Group Company Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

See Also: Call Option

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.